Investigative Urology - Results from #5500

Germline prognostic markers for urinary bladder cancer: Obstacles and opportunities - Abstract October 1, 2012

Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells - Abstract September 28, 2012

Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course - Abstract September 28, 2012

Metallothionein 2A genetic polymorphisms and risk of prostate cancer in a Polish population - Abstract September 28, 2012

Current concepts and significance of estrogen receptor β in prostate cancer - Abstract September 28, 2012

C-X-C chemokine receptor 7: A functionally associated molecular marker for bladder cancer - Abstract September 28, 2012

Tumor establishment features of orthotopic murine bladder cancer models - Abstract September 28, 2012

Mitochondrial haplogroups and polymorphisms reveal no association with sporadic prostate cancer in a southern European population - Abstract September 27, 2012

Validation of a sequential extraction and liquid chromatography-tandem mass spectrometric method for determination of dihydrotestosterone, androstanediol and androstanediol-glucuronide in prostate tissues - Abstract September 27, 2012

Mifepristone inhibits GRβ coupled prostate cancer cell proliferation - Abstract September 27, 2012

Oxysterol receptors, AKT and prostate cancer - Abstract September 27, 2012

KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation - Abstract September 27, 2012

Synergistic killing effect of chloroquine and androgen deprivation in LNCaP cells - Abstract September 27, 2012

Inhibition of Ca(2+)-activated Cl(-) channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma - Abstract September 27, 2012

Distinct roles of AKT isoforms in regulating β1-integrin activity, migration and invasion in prostate cancer - Abstract September 26, 2012

Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer - Abstract September 26, 2012

Anti-proliferative effect of 23,24-dihydrocucurbitacin F on human prostate cancer cells through induction of actin aggregation and cofilin-actin rod formation - Abstract September 26, 2012

Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma - Abstract September 26, 2012

Dual targeting of the Akt/mTOR signaling pathway inhibits castration-resistant prostate cancer in a genetically engineered mouse model - Abstract September 26, 2012

Potential use of STAT3 inhibitors in targeted prostate cancer therapy: Future prospects - Abstract September 26, 2012

Page 276 of 346